What the company does
TME Pharma N.V., a clinical-stage biopharmaceutical company, focuses on the development of proprietary therapeutics for the treatment of cancer in Germany. The company's Spiegelmer platform has a proprietary pipeline of clinical-stage product candidates, including its lead cancer drug candidate, NOX-A12, which is under development as a combination therapy for various cancer indications, such as metastatic pancreatic and colorectal cancer, and glioblastoma. It also developing NOX-E36, which has completed Phase 1/2a clinical trial for the treatment of diabetic nephropathy. The company was formerly known as NOXXON Pharma N.V. and changed its name to TME Pharma N.V. …
What the weekly tape is saying
ALTME closed the latest completed week at 0.08 EUR. The 4-week return is -0.1% and the 12-week return is 7.2%. Trend Signal is active, Market Dynamics is 2.18. Setup signature: Risk-first tape with a 39/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 0.07 EUR
- Vs Trend Line
- 9.0%
- Fair Value
- 0.26 EUR
- Vs Fair Value
- -69.5%
- 52W High
- 0.15 EUR
- 52W Low
- 0.05 EUR
- Drawdown
- -46.7%
- Range Position
- 30.2%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 4 weeks
- 52W Active Weeks
- 23
- 52W Active Breadth
- 44.2%
- Sector Scope
- FR Healthcare
- Sector Rank
- 57 of 76
- Sector Percentile
- 25.3%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
FR Healthcare
- Tracked Peers
- 76
- 4W Rank
- 26 of 76
- Avg 1W
- -2.1%
- Avg 4W
- -5.9%
- Trend Breadth
- 28.9%
- Positive MD
- 48.7%
FR Biotechnology
- Tracked Peers
- 33
- 4W Rank
- 9 of 33
- Avg 1W
- -2.8%
- Avg 4W
- -11.9%
- Trend Breadth
- 27.3%
- Positive RS
- 21.2%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 2.18
- 4W MD Change
- 127.7%
- Relative Strength
- -9.84
- 4W RS Change
- -69.3%
- Expectation
- Negative
- Probability
- 44.32%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 630.3K
- 13W Average
- 1.1M
- 52W Average
- 3.1M
- Vs 13W
- 0.6x
- Vs 52W
- 0.2x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 4.4%
- 52W Volatility
- 8.2%
- Upside Weeks
- 23
- Downside Weeks
- 28
- Downside Breadth
- 53.8%
- Avg Gain / Loss
- 6.4% / -4.9%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- PAR
- Country
- FR
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- EUR
- Market Cap
- 8.2M
Opportunity signals
- Trend Signal is active with a 4-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Market Dynamics is positive on the latest completed week.
Risk signals
- Price is below Fair Value, so the market is still discounting the latest tape.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 0.08 EUR | -3.3% | 0.07 EUR | 0.26 EUR | 2.18 | -9.84 | 630.3K | On |
| 5 Jun 2026 | 0.08 EUR | -5.2% | 0.07 EUR | 0.27 EUR | 1.97 | -5.50 | 805.2K | On |
| 29 May 2026 | 0.09 EUR | 6.6% | 0.07 EUR | 0.27 EUR | 1.61 | -0.08 | 587.6K | On |
| 22 May 2026 | 0.08 EUR | 2.3% | 0.07 EUR | 0.28 EUR | 1.25 | -5.49 | 1.7M | On |
| 15 May 2026 | 0.08 EUR | -0.3% | 0.07 EUR | 0.29 EUR | 0.96 | -5.81 | 615.4K | Off |
| 8 May 2026 | 0.08 EUR | 2.9% | 0.07 EUR | 0.30 EUR | 1.00 | -7.31 | 557.5K | Off |
| 1 May 2026 | 0.08 EUR | -0.9% | 0.07 EUR | 0.31 EUR | 0.83 | -9.86 | 690.4K | Off |
| 24 Apr 2026 | 0.08 EUR | -0.4% | 0.08 EUR | 0.32 EUR | 0.67 | -9.30 | 640.3K | Off |
| 17 Apr 2026 | 0.08 EUR | 10.2% | 0.08 EUR | 0.33 EUR | 0.62 | -11.68 | 5.7M | Off |
| 10 Apr 2026 | 0.07 EUR | 0.0% | 0.08 EUR | 0.34 EUR | 0.43 | -18.18 | 264.3K | Off |
| 3 Apr 2026 | 0.07 EUR | -5.2% | 0.08 EUR | 0.34 EUR | 0.63 | -15.32 | 445.2K | Off |
| 27 Mar 2026 | 0.07 EUR | 1.5% | 0.08 EUR | 0.35 EUR | 0.66 | -7.74 | 588.7K | Off |
| 20 Mar 2026 | 0.07 EUR | -4.4% | 0.08 EUR | 0.36 EUR | 0.62 | -8.47 | 1.2M | Off |
| 13 Mar 2026 | 0.08 EUR | 9.1% | 0.08 EUR | 0.36 EUR | 0.57 | -7.11 | 3.5M | Off |